Displaying archives for December 2014 - ALCMI - Addario Lung Cancer Medical Institute:

Exosome Diagnostics & ALCMI Announce Collaboration on Sequencing Blood

Posted by Steven Young on December 8th, 2014 |

CAMBRIDGE, Mass. and LOS ANGELES, Calif., Jan. 9, 2015 – Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced a strategic collaboration with the Addario Lung Cancer Medical Institute (ALCMI) to accelerate the development of its lead plasma-based diagnostics in development for mutation detection and monitoring in patients with lung cancer. The […]